A Phase III Randomized Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion (ECOG 1208)
What is the purpose of this trial?
- 18 Years and older
- National Cancer Institute (NCI)
- April 2011
- Last Updated:
- Study HIC#:
Clinicaltrials.gov ID: Yale5024181